Metastatic Breast Cancer Treatment
When breast cancer spreads to another part of the body, it is considered metastatic breast cancer. Metastases may develop in multiple organs and can show up as multiple tumors or lesions. Breast cancer metastasized to the lung is the most common diagnosis, developing in 80 percent of people who have a metastasis. Metastatic breast cancer in the liver happens in 50 percent of cases. Other organs are also involved in 50 percent of cases.
The UF Health Metastatic Cancer Program’s integrated strategy offers comprehensive treatment through an aggressive new approach, working collaboratively with a patient’s existing medical oncologist and in tandem with standard chemotherapy.
The best chance at managing metastatic breast cancer is to act at the first sign of symptoms or immediately upon diagnosis. The UF Health Metastatic Cancer Program treats patients who have 10 or fewer new lesions.
Our method for treating cancer uses a targeted type of radiation called stereotactic body radiation therapy (SBRT) to pinpoint the metastatic lesions and destroy them on contact. Because SBRT has the ability to eliminate tumors with less damage to healthy tissue and a more comfortable recovery time than other methods for removal, it is particularly beneficial for patients who are not candidates for surgery.
Our method for treating cancer uses a targeted type of radiation called stereotactic body radiation therapy (SBRT) to pinpoint the metastatic lesions and destroy them on contact. Because SBRT has the ability to eliminate tumors with less damage to healthy tissue and a more comfortable recovery time than other methods for removal, it is particularly beneficial for patients who are not candidates for surgery.
Additional therapies at the UF Health Metastatic Cancer Program include:
- Tumor immune therapy
- Tumor vaccine therapy
- Tumor anti-vascular therapy
- Surgery
- Interventional pulmonology
- Interventional radiology procedures
- Chemotherapy